Sim4Flow: Pioneering the Future of Aneurysm Management

 

At Sim4Flow, we’re dedicated to transforming the way intracranial aneurysms are managed through cutting-edge AI technology. Our innovative platform, IRIS, offers clinicians a powerful tool for precise risk prediction and treatment planning.

Our Mission

To empower healthcare providers with the tools and technology needed to better understand and manage intracranial aneurysms, improving patient outcomes and reducing the risks associated with this life-threatening condition.

Our Vision

A world where intracranial aneurysms are managed with precision and confidence, ensuring that patients receive the best possible care.

Our Story

Sim4Flow was born out of a passion for innovation and a desire to address the critical challenges of aneurysm management. Our team of experts in biomedical engineering, AI, and clinical research, recognized the potential for advanced AI-driven solutions to revolutionize neurovascular care.

In 2024, we received €120k pre-seed funding from the competitive RIF call, propelling us forward in our mission to bring IRIS to reality. Today, we’re proud to be at the forefront of AI-based aneurysm risk prediction, empowering clinicians with the tools they need to make informed decisions and deliver exceptional patient care.

Our Values

Innovation

We're committed to pioneering advancements in healthcare through cutting-edge AI and machine learning technologies.

Collaboration

Working closely with clinicians and researchers worldwide, we believe that teamwork is essential to success.

Patient-Centered

Our primary goal is to enhance patient outcomes, providing tools that allow for personalized and precise healthcare decisions.

Integrity

We uphold the highest ethical standards in our research, technology, and operations.

Continuous Improvement

We're dedicated to continually refining our technology to meet the evolving needs of healthcare providers and patients.

Ready to learn more about IRIS?